Letter to the Editor Re: Ahn DH, Krishna K, Blazer M, . “A modified regimen of biweekly gemcitabine and -paclitaxel in patients with metastatic pancreatic cancer is both tolerable...

by Daniel D Von Hoff, Markus F Renschler
Published 2017-06-01

Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of Pancreatic Cancer Cells.

by Aditi A Bapat, Ruben M Munoz, Daniel D Von Hoff, Haiyong Han
Published 2016-01-01

Role of 3D Volumetric and Perfusion Imaging for Detecting Early Changes in Pancreatic Adenocarcinoma

by Syed Rahmanuddin, Ronald Korn, Derek Cridebring, Erkut Borazanci, Jordyn Brase, William Boswell, Asma Jamil, Wenli Cai, Aqsa Sabir, Pejman Motarjem, Eugene Koay, Anirban Mitra, Ajay Goel, Joyce Ho, Vincent Chung, Daniel D. Von Hoff, Daniel D. Von Hoff, Daniel D. Von Hoff
Published 2021-09-01

Molecular characterization of interdigitating dendritic cell sarcoma

by Robert J. Penny, Daniel D. Von Hoff, Arlet Alarcon, Maqbool Halepota, Glen J. Weiss
Published 2010-09-01

Inhibition of ROCK1 kinase modulates both tumor cells and stromal fibroblasts in pancreatic cancer.

by Clifford J Whatcott, Serina Ng, Michael T Barrett, Galen Hostetter, Daniel D Von Hoff, Haiyong Han
Published 2017-01-01

Clonal evolution and therapeutic resistance in solid tumors

by Elizabeth eLenkiewicz, Lisa eEvers, Tara eHolley, Christian eRuiz, Lukas eBubendorf, Aleksander eSekulic, Ramesh K Ramanathan, Ramesh K Ramanathan, Daniel D Von Hoff, Daniel D Von Hoff, Michael T Barrett, Michael T Barrett
Published 2013-01-01

Molecular Characterization of a Patient's Small Cell Carcinoma of the Ovary of the Hypercalcemic Type

by Bret Stephens, Stephen P. Anthony, Haiyong Han, Jeffery Kiefer, Galen Hostetter, Michael Barrett, Daniel D. Von Hoff
Published 2012-01-01

Progression-free Survival Decreases with Each Subsequent Therapy in Patients Presenting for Phase I Clinical Trials

by Christopher H. Bailey, Gayle Jameson, Chao Sima, Sharon Fleck, Erica White, Daniel D. Von Hoff, Glen J. Weiss
Published 2012-01-01

Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome

by Glen J. Weiss, Raoul Tibes, Lisa Blaydorn, Gayle Jameson, Molly Downhour, Erica White, Ivor Caro, Daniel D. Von Hoff
Published 2011-12-01

Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells.

by Caroline H Diep, Kelly M Zucker, Galen Hostetter, Aprill Watanabe, Chengcheng Hu, Ruben M Munoz, Daniel D Von Hoff, Haiyong Han
Published 2012-01-01

18F-FDG PET/CT response in a phase 1/2 trial of nab-paclitaxel plus gemcitabine for advanced pancreatic cancer

by Ronald L. Korn, Daniel D. Von Hoff, Mitesh J. Borad, Markus F. Renschler, Desmond McGovern, R. Curtis Bay, Ramesh K. Ramanathan
Published 2017-08-01

The Impact of Concomitant Medication Use on Patient Eligibility for Phase I Cancer Clinical Trials

by Mitesh J. Borad, Kelly K. Curtis, Hani M. Babiker, Martin Benjamin, Raoul Tibes, Ramesh K. Ramanathan, Karen Wright, Amylou C. Dueck, Gayle Jameson, Daniel D. Von Hoff
Published 2012-01-01

Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions

by Wei Lin, Pawan Noel, Erkut H. Borazanci, Jeeyun Lee, Albert Amini, In Woong Han, Jin Seok Heo, Gayle S. Jameson, Cory Fraser, Margaux Steinbach, Yanghee Woo, Yuman Fong, Derek Cridebring, Daniel D. Von Hoff, Joon Oh Park, Haiyong Han
Published 2020-09-01

Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma.

by Glen J Weiss, Winnie S Liang, Tyler Izatt, Shilpi Arora, Irene Cherni, Robert N Raju, Galen Hostetter, Ahmet Kurdoglu, Alexis Christoforides, Shripad Sinari, Angela S Baker, Raghu Metpally, Waibhav D Tembe, Lori Phillips, Daniel D Von Hoff, David W Craig, John D Carpten
Published 2012-01-01

A pilot study using next-generation sequencing in advanced cancers: feasibility and challenges.

by Glen J Weiss, Winnie S Liang, Michael J Demeure, Jeff A Kiefer, Galen Hostetter, Tyler Izatt, Shripad Sinari, Alexis Christoforides, Jessica Aldrich, Ahmet Kurdoglu, Lori Phillips, Hollie Benson, Rebecca Reiman, Angela Baker, Vickie Marsh, Daniel D Von Hoff, John D Carpten, David W Craig
Published 2013-01-01

Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pre-Diagnostic Period: Implications for Early Detection

by Mohamed Zaid, Dalia Elganainy, Prashant Dogra, Annie Dai, Lauren Widmann, Pearl Fernandes, Zhihui Wang, Maria J. Pelaez, Javier R. Ramirez, Aatur D. Singhi, Anil K. Dasyam, Randall E. Brand, Walter G. Park, Syed Rahmanuddin, Michael H. Rosenthal, Brian M. Wolpin, Natalia Khalaf, Ajay Goel, Daniel D. Von Hoff, Eric P. Tamm, Anirban Maitra, Vittorio Cristini, Eugene J. Koay
Published 2020-12-01

Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers

by Mitesh J. Borad, Jan B. Egan, Rachel M. Condjella, Winnie S. Liang, Rafael Fonseca, Nicole R. Ritacca, Ann E. McCullough, Michael T. Barrett, Katherine S. Hunt, Mia D. Champion, Maitray D. Patel, Scott W. Young, Alvin C. Silva, Thai H. Ho, Thorvardur R. Halfdanarson, Robert R. McWilliams, Konstantinos N. Lazaridis, Ramesh K. Ramanathan, Angela Baker, Jessica Aldrich, Ahmet Kurdoglu, Tyler Izatt, Alexis Christoforides, Irene Cherni, Sara Nasser, Rebecca Reiman, Lori Cuyugan, Jacquelyn McDonald, Jonathan Adkins, Stephen D. Mastrian, Riccardo Valdez, Dawn E. Jaroszewski, Daniel D. Von Hoff, David W. Craig, A. Keith Stewart, John D. Carpten, Alan H. Bryce
Published 2016-12-01